S&P 5005,842.31+28.45 (+0.49%)
NASDAQ18,672.50+142.30 (+0.77%)
DOW 3043,285.10-52.80 (-0.12%)
Russell 20002,095.40+15.20 (+0.73%)
VIX14.85-0.62 (-4.01%)
Bitcoin98,420.00+2150.00 (+2.23%)
10-Yr Bond4.28-0.03 (-0.70%)
Gold2,845.30+12.40 (+0.44%)
Oil (WTI)74.85-1.15 (-1.51%)
S&P 5005,842.31+28.45 (+0.49%)
NASDAQ18,672.50+142.30 (+0.77%)
DOW 3043,285.10-52.80 (-0.12%)
Russell 20002,095.40+15.20 (+0.73%)
VIX14.85-0.62 (-4.01%)
Bitcoin98,420.00+2150.00 (+2.23%)
10-Yr Bond4.28-0.03 (-0.70%)
Gold2,845.30+12.40 (+0.44%)
Oil (WTI)74.85-1.15 (-1.51%)

JNJ

NYSE

Johnson & Johnson

$162.80
-0.45 (-0.28%)

About Johnson & Johnson

Johnson & Johnson researches, develops, manufactures, and sells various products in the healthcare field worldwide, focusing on innovative medicine and MedTech segments.

Key Statistics

Market Cap
$393B
P/E Ratio
16.2
Volume
6.5M
52W High
$175.50
52W Low
$144.90
Sector
Healthcare

Latest JNJ News

News2026-02-05

Johnson & Johnson Beats Earnings Expectations, Raises Guidance

JNJ reports stronger-than-expected quarterly results driven by robust demand and operational efficiency improvements.

News2026-02-04

Analysts Upgrade JNJ on Strong Growth Outlook

Multiple Wall Street firms raise their price targets for Johnson & Johnson citing accelerating revenue growth and expanding margins.

News2026-02-03

Johnson & Johnson Announces Strategic Partnership

JNJ enters into a strategic collaboration expected to drive innovation and unlock new growth opportunities.

Quick Facts

ExchangeNYSE
SectorHealthcare
Market Cap$393B
P/E Ratio16.2
Daily Volume6.5M